The landscape of digital health in South Korea is undergoing a critical transformation. As regulatory bodies tighten oversight on telehealth services, upcoming legal and administrative frameworks are set to reshape how virtual medical platforms, community pharmacies, and delivery networks interact. With the Ministry of Health and Welfare driving toward a targeted implementation date of December 24, healthcare professionals—particularly pharmacists—must prepare for stricter compliance protocols.

Protecting Professional Autonomy

A major focal point of the newly proposed "Enactment Proposal on the Implementation and Management of Non-Face-to-Face Medical Treatment" is the safeguarding of pharmacist independence. Under the upcoming rules, telehealth platforms will be strictly barred from penalizing pharmacies, restricting their platform visibility, or lowering their search rankings simply because a pharmacist exercised professional discretion in verifying, questioning, or dispensing a prescription.

Furthermore, platforms can no longer manipulate search results using metrics like prescription volume, drug delivery performance, or a medical provider’s prescription frequency. To maintain a fair marketplace, pharmacy listings must be sorted strictly by objective metrics such as geographic distance and operating hours. Practices designed to funnel patients toward specific pharmacies—such as copay discounting, point rewards, unfair delivery fee structuring, or anti-visit advertising—are also prohibited, and platforms are mandated to archive their exposure algorithms and modification histories for three years.

Tightening Medication Delivery and Safety Standards

The new guidelines enforce rigorous controls over how medications travel from the dispensary to the patient. As a rule, non-face-to-face medication delivery is restricted to the same city, county, and district (si-gun-gu) as the patient's registered address, with narrow exceptions for rare disease patients and those in medically vulnerable regions.

Physical handovers must occur directly with the patient or an authorized proxy. While delivery tasks can be outsourced to designated courier services, sub-contracting is strictly forbidden. Couriers must utilize dedicated pharmaceutical transport boxes, adhere to strict storage parameters, and refrain from transporting drugs alongside food or hazardous materials. Pharmacies retain the ultimate right to refuse remote delivery if the clinical nature of the drug makes it unsuitable, and detailed liability and compensation frameworks for lost or damaged goods must be integrated into operational terms.

Refining Restrictions on Initial Consultations and High-Risk Drugs

The regulatory package also draws clear boundaries around prescription eligibility. General telehealth sessions prohibit the remote issuance of narcotics, psychotropic medications, substance-abuse risks, emergency contraceptives, and specific weight-loss agents (such as orlistat, liraglutide, and semaglutide), though formulations intended strictly for other conditions like diabetes remain protected. Furthermore, oral agents containing isotretinoin or tramadol are restricted during initial virtual visits.

An "initial visit" is defined as any consultation where the patient has not seen a doctor at that specific institution for the same symptom within the past six months. Accompanying amendments to the Enforcement Rule of the Medical Service Act mandate that initial telehealth sessions be conducted by clinics within the patient’s local city or province (si-do), capping initial prescriptions at seven days unless clinical continuity necessitates an extension up to 30 days.

Looking Ahead

With platforms boasting over 100,000 subscribers required to secure official certification and state-backed agencies stepping in to oversee digital infrastructure, South Korea's telehealth sector is transitioning from a period of rapid expansion into a highly regulated ecosystem. As the public comment window closes and the December rollout approaches, stakeholders across the healthcare continuum must align their operations with these elevated standards of patient safety and professional integrity.

[Copyright (c) Global Economic Times. All Rights Reserved.]